Canis Computer Laboratories, and now CCL Billing, Inc. Serving your Business's Needs Since 2018.
Specialty Billing

Laboratory Billing Services

High-volume, low-dollar, rule-dense — laboratory billing rewards precision at scale. We bill clinical, pathology, molecular, and physician-office labs so every requisition turns into a paid claim.

Built for the Economics of Laboratory Claims

A laboratory bills thousands of claims a month, most of them small, all of them governed by rules that change by payer and by test: organ and disease panels that must be billed as a unit, modifier 91 for medically necessary repeat tests, QW for CLIA-waived methods, diagnosis codes that have to satisfy a specific coverage policy, and an ordering provider whose NPI must be valid on every line. At that volume, a two-percent error rate is a five-figure monthly leak. CCL Billing runs laboratory billing as a production system — requisition data validated before the claim exists, panels and modifiers applied by rule, medical necessity checked against the payer being billed, and rejections worked the same day — for independent labs, pathology groups, molecular and toxicology labs, and physician-office laboratories across the United States.

Laboratory technologist pipetting samples in a clinical lab

Photo: National Cancer Institute, public domain

What We Handle for Laboratories

Panel and bundling logic icon

Panel & Bundling Logic

Organ and disease panels, NCCI edits, and component-versus-panel rules applied before submission, so claims aren't rejected for unbundling or underpaid for missed components.

Medical necessity icon

Medical Necessity & Coverage

Diagnosis linkage checked against national and local coverage determinations and payer policy for each test, with ABNs issued when a test isn't covered.

Modifiers icon

Modifiers 91, QW, 59 & 26/TC

Repeat tests, CLIA-waived methods, distinct services, and pathology professional-versus-technical splits coded to what actually happened.

Requisition data icon

Requisition & Ordering-Provider Data

Ordering and referring NPIs, patient demographics, and insurance validated at accessioning — the single largest source of laboratory rejections, fixed at the source.

Molecular and prior authorization icon

Molecular, MolDX & Prior Auth

Test registration, Z-code identifiers, MolDX documentation, and prior authorizations for high-dollar molecular and genetic tests secured before the sample is run.

Automation icon

High-Volume Automation

Interface-driven charge capture from your LIS, claim scrubbing at scale, and Canis AI denial-risk scoring — with human review where it changes the outcome.

Revenue increase icon 20%Increase in Revenue
Reduced accounts receivable icon 35%Reduced A/R
Fast turnaround icon 7 DaysMinimal Turn Around
Remittance ratio icon 90%Remittance Ratios
Aging accounts receivable icon 15%Collected Aging A/R

Where Laboratory Revenue Leaks — and How We Stop It

Laboratory billing fails in a different place than physician billing. A physician claim usually fails on coding or documentation; a laboratory claim usually fails before the test is even run, on the requisition. A diagnosis code that doesn't satisfy the payer's coverage policy for that assay, an ordering provider whose NPI isn't enrolled or isn't on the form, a missing date of collection, or insurance that was never verified will each produce a denial that no amount of downstream appeal work fixes efficiently. That is why we start at accessioning: requisition completeness and eligibility are validated when the sample arrives, so the claim that is eventually built is one the payer can actually pay.

From there the rules multiply. Clinical chemistry and hematology panels must be billed as the defined panel when every component is performed, and as components when they aren't. Repeat tests on the same day need modifier 91 and the clinical reason behind them; CLIA-waived methods need QW; pathology services split into professional and technical components with 26 and TC; and drug-testing claims carry presumptive-versus-definitive coding that payers audit closely. Molecular and genetic testing adds MolDX documentation and Z-code identifiers in participating Medicare jurisdictions, prior authorization on most commercial and Medicaid plans, and the highest dollar values on the ticket — which is why we treat every molecular claim as a pre-submission review, not a post-denial appeal. Hospital outreach laboratories also have to respect the date-of-service rules that decide whether a test is billed by the hospital or by the lab.

Volume changes the economics of all of this. Where a practice might rework a hundred denials a month by hand, a laboratory faces thousands of small claims, and the only sustainable approach is a system: interface-driven charge capture from the laboratory information system, rule-based panel and modifier application, claim scrubbing at scale, and Canis AI denial-risk scoring that routes the exceptions to a human before submission. CCL Billing was founded by a Columbia University–trained biomedical informatics specialist, and that systems background is what makes laboratory accounts predictable: fewer touches per claim, faster rejections cycles, and reporting that breaks out collections by test category, payer, and ordering client. For New York laboratories, we also work within the Department of Health's Clinical Laboratory Evaluation Program requirements and the state's Medicaid and managed care rules that add a layer on top of federal policy.

How We Make Laboratory Revenue Predictable

1. Requisition & Denial Audit

We sample requisitions and denials by test category and payer, quantify the leak at accessioning versus coding versus payer policy, and show you where the revenue is going.

2. Interface & Rules Setup

We connect to your LIS and billing platform, configure panel, modifier, and coverage rules per payer, and start working the existing backlog without interrupting test throughput.

3. Tracked Results

Monthly reporting by test category, payer, and client compares clean-claim rate, denial rate, and collections against your baseline — so you always know the operation is improving.

Laboratory Billing FAQ

Which types of laboratories do you bill for?

Independent clinical laboratories, anatomic and clinical pathology groups, molecular diagnostic and toxicology labs, hospital outreach laboratories, and physician-office labs running CLIA-waived or moderate-complexity testing. Each has a different mix of payers, panel rules, and medical-necessity policies, and we set up the billing workflow around that mix.

Why do laboratory claims get denied so often?

Most lab denials trace to four causes: a diagnosis code on the requisition that doesn't meet the payer's coverage policy for the test; missing or invalid ordering-provider information; panel and bundling errors; and modifier mistakes, especially modifier 91 for repeat tests and QW for CLIA-waived tests. All four are preventable before submission.

Do you handle molecular and genetic test billing?

Yes. Molecular tests carry their own layer of rules — MolDX program requirements in participating Medicare jurisdictions, test registration and Z-code identifiers, prior authorization for many commercial and Medicaid plans, and tight medical-necessity documentation. We build those requirements into the front end so high-dollar molecular claims are not left to appeal.

Do you work with laboratories in New York?

Yes. From our Albany headquarters we serve labs across New York State — where the Department of Health's Clinical Laboratory Evaluation Program permit, New York Medicaid, and the state's managed care plans add requirements on top of federal rules — as well as laboratories nationwide.

Contact Us

Get in Touch

Tell us about your laboratory — test menu, monthly volume, payer mix, and where claims are getting stuck. One of our experts will reach out to review your current billing operation and map out what we would fix.

By submitting, you agree to the site Terms & Conditions and Privacy Policy.